Bank Of America Corp Novo Nordisk A S Transaction History

Bank Of America Corp

$1.21 Trillion
Q1 2025

A detailed history of Bank Of America Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, Bank Of America Corp holds 14,792,624 shares of NVO stock, worth $736 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

14,792,624

Previous 15,492,384 4.52%

Holding current value

$736 Million

Previous $1.33 Billion 22.92%

% of portfolio

0.08%

Previous 0.11%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$69.3 - $90.95 $48.5 Million - $63.6 Million	-699,760 Reduced 4.52%	14,792,624 $1.03 Billion
Q4 2024 Feb 14, 2025	BUY	$85.0 - $120.04 $99.1 Million - $140 Million	1,165,955 Added 8.14%	15,492,384 $1.33 Billion
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $16.3 Million - $19.9 Million	137,066 Added 0.97%	14,326,429 $1.71 Billion
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $139 Million - $167 Million	1,135,632 Added 8.7%	14,189,363 $2.03 Billion
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $8 Million - $10.6 Million	78,322 Added 0.6%	13,053,731 $1.68 Billion
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $592 Million - $711 Million	6,746,377 Added 108.31%	12,975,409 $1.34 Billion
Q2 2023 Aug 14, 2023	SELL	$155.98 - $172.65 $14.6 Million - $16.2 Million	-93,563 Reduced 1.48%	6,229,032 $1.01 Billion
Q1 2023 May 12, 2023	SELL	$132.34 - $159.14 $58.3 Million - $70.1 Million	-440,661 Reduced 6.52%	6,322,595 $1.01 Billion
Q4 2022 Feb 10, 2023	SELL	$102.55 - $135.33 $57.3 Million - $75.6 Million	-558,380 Reduced 7.63%	6,763,256 $915 Million
Q3 2022 Nov 14, 2022	SELL	$95.28 - $116.93 $13.8 Million - $17 Million	-145,136 Reduced 1.94%	7,321,636 $729 Million
Q2 2022 Aug 12, 2022	BUY	$103.24 - $121.81 $2.7 Million - $3.19 Million	26,163 Added 0.35%	7,466,772 $832 Million
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $11.8 Million - $14.2 Million	126,438 Added 1.73%	7,440,609 $826 Million
Q4 2021 Feb 08, 2022	SELL	$95.88 - $117.08 $14.1 Million - $17.2 Million	-147,235 Reduced 1.97%	7,314,171 $819 Million
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $13.3 Million - $16.7 Million	156,956 Added 2.15%	7,461,406 $716 Million
Q2 2021 Sep 13, 2021	BUY	$67.66 - $84.76 $494 Million - $619 Million	7,304,450 New	7,304,450 $612 Million

Others Institutions Holding NVO

# of Institutions

1,748

Shares Held

332M

Call Options Held

10.5M

Put Options Held

16.2M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $112B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Novo Nordisk A S Transaction History